1220
T. Lessing et al.
Letter
Synlett
Table 1 (continued)
Entry
2-Aminopyridylhalide 1
Alkyne 2
Product
Yield (%)a
F3C
Ph
18
3-bromo-5-(trifluoromethyl)pyridin-2-amine (1d) 2a
4r (66)
N
H
N
N
F3C
t-Bu
19
1d
2c
4s (54)
N
H
a Yields are the isolated yields after column chromatography.
b The synthetic procedure differed from the general procedure in that 3.4 equiv of KOt-Bu were used.
In summary, we have disclosed a practical, efficient and
rapid novel Cu-free Pd-catalyzed alkynylation–cyclization
sequence in a one-pot fashion, furnishing 2-substituted and
2,5-disubstituted 7-azaindoles in good yields dispensing
with protection of the amino nitrogen at any time in the se-
quence. Further studies employing this novel access to sub-
stituted 7-azaindoles in complex molecules’ syntheses are
currently underway.
(2) (a) Lorenz, R. R.; Tullar, B. F.; Koelsch, C. F.; Archer, S. J. Org.
Chem. 1965, 30, 2531. (b) Herbert, R.; Wibberley, D. G. J. Chem.
Soc. C 1969, 1505. (c) Houlihan, W. J.; Parrino, V. A.; Uike, Y.
J. Org. Chem. 1981, 46, 4511.
(3) For a review summarizing syntheses, see: Mérour, J.-Y.; Routier,
S.; Suzenet, F.; Joseph, B. Tetrahedron 2013, 69, 476.
(4) (a) Fang, Y.-Q.; Yuen, J.; Lautens, M. J. Org. Chem. 2007, 72, 5152.
(b) Parcerisa, J.; Romero, M.; Pujol, M. D. Tetrahedron 2008, 64,
500. (c) Kurhade, S.; Rajopadhyay, V.; Avaragolla, S. V.; Koul, S.;
Ramaiah, P. A.; Bhuniya, D. Tetrahedron Lett. 2014, 55, 2415.
(d) Rodriguez, A. L.; Koradin, C.; Dohle, W.; Knochel, P. Angew.
Chem. Int. Ed. 2000, 39, 2488; Angew. Chem. 2000, 112, 2607.
(e) de Mattos, M. C.; Alatorre-Santamaría, S.; Gotor-Fernández,
V.; Gotor, V. Synthesis 2007, 2149. (f) Harcken, C.; Yancey, W.;
Thomson, D.; Riether, D. Synlett 2005, 3121. (g) Majumdar, K. C.;
Mondal, S. Tetrahedron Lett. 2007, 48, 6951.
Acknowledgment
The authors cordially thank the Fonds der Chemischen Industrie (sti-
pend for T.L.) for financial support.
(5) (a) Carpita, A.; Ribecai, A.; Stabile, P. Tetrahedron 2010, 66,
7169. (b) Schirok, H. J. Org. Chem. 2006, 71, 5538. (c) Cottineau,
B.; O’Shea, D. F. Tetrahedron Lett. 2005, 46, 1935. (d) Cottineau,
B.; O’Shea, D. F. Tetrahedron 2007, 63, 10354.
(6) Leboho, T. C.; van Vuuren, S. F.; Michael, J. P.; de Koning, C. B.
Org. Biomol. Chem. 2014, 12, 307.
Supporting Information
Supporting information for this article is available online at
S
u
p
p
ortiInfogrmoaitn
S
u
p
p
ortioInfgrmoaitn
(7) (a) Nordmann, J.; Müller, T. J. J. Synthesis 2014, 46, 522.
(b) Nordmann, J.; Müller, T. J. J. Org. Biomol. Chem. 2013, 11,
6556. (c) Nordmann, J.; Breuer, N.; Müller, T. J. J. Eur. J. Org.
Chem. 2013, 4303.
(8) (a) Goehrlich, J. R.; Schmutzler, R. Phosphorus, Sulfur Silicon
Relat. Elem. 1995, 102, 211. (b) Beller, M.; Hein, M.; Tewari, A.;
Zapf, A. Synthesis 2004, 935.
(9) Typical Procedure for the Synthesis of 2-Phenyl-1H-pyr-
rolo[2,3-b]pyridine (4a): In a flame-dried Schlenk tube under
nitrogen atmosphere, 3-bromopyridine-2-amine (1a; 173 mg,
1.00 mmol), Pd(PPh3)2Cl2 (17.5 mg, 0.025 mmol), and (1-
Ad)2PBn·HBr (22.6 mg, 0.050 mmol) were dissolved in anhyd
DMSO (1.50 mL). Phenylacetylene (2a; 122 mg, 1.20 mmol) and
DBU (457 mg, 3.00 mmol) were added via syringe and the reac-
tion mixture was stirred in a preheated oil bath at 100 °C until
complete conversion of compound 1a (monitored by TLC). Then,
KOt-Bu (281 mg, 2.5 mmol) and anhyd DMSO (1.00 mL) were
added and the mixture was stirred at 100 °C until completion of
the reaction (monitored by TLC). After cooling to r.t., de-ionized
H2O (2.00 mL) was added and the aqueous layer was extracted
three times with EtOAc. The combined organic phases were first
washed twice with de-ionized H2O and then dried with anhyd
Na2SO4. The solvents were removed under reduced pressure.
The residue was adsorbed onto Celite® and purified by column
References and Notes
(1) For the recent development and synthesis of several kinase
inhibitors, see, for example: (a) Chowdhury, S.; Sessions, E. H.;
Pocas, J. R.; Grant, W.; Schroter, T.; Lin, L.; Ruiz, C.; Cameron, M.
D.; Schurer, S.; LoGrasso, P.; Bannister, T. D.; Feng, Y. Bioorg.
Med. Chem. Lett. 2011, 21, 7107. (b) Liddle, J.; Bamborough, P.;
Barker, M. D.; Campos, S.; Cousins, R. P.; Cutler, G. J.; Hobbs, H.;
Holmes, D. S.; Ioannou, C.; Mellor, G. W.; Morse, M. A.; Payne, J.
J.; Pritchard, J. M.; Smith, K. J.; Tape, D. T.; Whitworth, C.;
Williamson, R. A. Bioorg. Med. Chem. Lett. 2009, 19, 2504.
(c) Adams, J. L.; Burgess, J. L.; Chaudhari, A. M.; Copeland, R. A.;
Donatelli, C. A.; Drewry, D. H.; Fisher, K. E.; Hamajima, T.;
Hardwicke, M. A.; Huffman, W. F.; Koretke-Brown, K. K.; Lai, Z.
V.; McDonald, O. B.; Nakamura, H.; Newlander, K. A.;
Oleykowski, C. A.; Parrish, C. A.; Patrick, D. R.; Plant, R.; Sarpong,
M. A.; Sasaki, K.; Schmidt, S. J.; Silva, D. J.; Sutton, D.; Tang, J.;
Thompson, C. S.; Tummino, P. J.; Wang, J. C.; Xiang, H.; Yang, J.;
Dhanak, D. J. Med. Chem. 2010, 53, 3973. (d) Chevé, G.; Bories,
C.; Fauvel, B.; Picot, F.; Tible, A.; Daydé-Cazals, B.; Loget, O.;
Yasri, A. Med. Chem. Commun. 2012, 3, 788.
© Georg Thieme Verlag Stuttgart · New York — Synlett 2015, 26, 1217–1221